Literature DB >> 18926541

Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia.

Angelo B Cefalù1, Davide Noto, Lucia Magnolo, Elisa Pinotti, Monica Gomaraschi, Scipione Martini, Giovanni B Vigna, Laura Calabresi, Patrizia Tarugi, Maurizio R Averna.   

Abstract

Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that catalyses the transfer of cholesteryl esters from HDL to the other plasma lipoproteins. Genetic deficiency of CETP is one of the known causes of elevation of plasma HDL-C (primary hyperalphalipoproteinemia, HALP). We sequenced CETP gene in a group of 24 Italian subjects with primary HALP (HDL-C>80 mg/dl) suspected to have CETP deficiency. Two unrelated subjects both coming from the same geographical district, were found to be heterozygous for a nucleotide substitution in exon 6 (c.544C>T) and another subject was found to be heterozygous for a C>T transition in exon 9 (c.802C>T). Both mutations introduce a premature stop codon and are predicted to cause the production of truncated proteins (Q165X and R268X, respectively) devoid of function. The fourth proband was found to carry a T>C substitution in intron 15 (c.1407+2T>C) predicted to abolish the function of the donor splice site. To define the effect of this mutation on CETP pre-mRNA splicing we analysed CETP mRNA in COS-1 cells expressing a CETP minigene harbouring the mutation. The analysis of minigene transcript in COS-1 cells showed that IVS15+2T>C mutation caused the formation of an abnormal mRNA in which exon 14 joins directly to exon 16, predicted to encode a truncated peptide of 435 amino acids. In mutation carriers plasma CETP activity was found to be reduced by 38-60%. These are the first mutations in the CETP gene found in Italian subjects with HALP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926541     DOI: 10.1016/j.atherosclerosis.2008.08.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

Review 1.  Beyond statins: new lipid lowering strategies to reduce cardiovascular risk.

Authors:  Davide Noto; Angelo B Cefalù; Maurizio R Averna
Journal:  Curr Atheroscler Rep       Date:  2014-06       Impact factor: 5.113

Review 2.  Alternative splicing in the regulation of cholesterol homeostasis.

Authors:  Marisa W Medina; Ronald M Krauss
Journal:  Curr Opin Lipidol       Date:  2013-04       Impact factor: 4.776

Review 3.  Unique features of high-density lipoproteins in the Japanese: in population and in genetic factors.

Authors:  Shinji Yokoyama
Journal:  Nutrients       Date:  2015-04-02       Impact factor: 5.717

Review 4.  Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP.

Authors:  Shinji Yokoyama; Kuniko Okumura-Noji; Rui Lu
Journal:  J Biomed Res       Date:  2015-04-15

5.  Heritability and genetic associations of triglyceride and HDL-C levels using pedigree-based and empirical kinships.

Authors:  Nicholas B Blackburn; Arthur Porto; Juan M Peralta; John Blangero
Journal:  BMC Proc       Date:  2018-09-17

6.  Hibernating brown bears are protected against atherogenic dyslipidemia.

Authors:  Chantal Simon; Stéphane Blanc; Sylvain Giroud; Isabelle Chery; Mathilde Arrivé; Michel Prost; Julie Zumsteg; Dimitri Heintz; Alina L Evans; Guillemette Gauquelin-Koch; Jon M Arnemo; Jon E Swenson; Etienne Lefai; Fabrice Bertile
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

Review 7.  HDL Receptor in Schistosoma japonicum Mediating Egg Embryonation: Potential Molecular Basis for High Prevalence of Cholesteryl Ester Transfer Protein Deficiency in East Asia.

Authors:  Shinji Yokoyama
Journal:  Front Cell Dev Biol       Date:  2022-03-17

8.  High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity.

Authors:  Sandrine Chantepie; Andrea E Bochem; M John Chapman; G Kees Hovingh; Anatol Kontush
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

9.  eNOS activation by HDL is impaired in genetic CETP deficiency.

Authors:  Monica Gomaraschi; Alice Ossoli; Silvia Pozzi; Peter Nilsson; Angelo B Cefalù; Maurizio Averna; Jan Albert Kuivenhoven; G Kees Hovingh; Fabrizio Veglia; Guido Franceschini; Laura Calabresi
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.